Idiopathic thrombocytopenic purpura pathophysiology
|
Idiopathic thrombocytopenic purpura Microchapters |
|
Differentiating Idiopathic thrombocytopenic purpura from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Idiopathic thrombocytopenic purpura pathophysiology On the Web |
|
American Roentgen Ray Society Images of Idiopathic thrombocytopenic purpura pathophysiology |
|
Idiopathic thrombocytopenic purpura pathophysiology in the news |
|
Blogs on Idiopathic thrombocytopenic purpura pathophysiology |
|
Directions to Hospitals Treating Idiopathic thrombocytopenic purpura |
|
Risk calculators and risk factors for Idiopathic thrombocytopenic purpura pathophysiology |
increased platelet destructionEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
AITP is characterized by the production of autoreactive antibodies against one's own platelets, resulting in increased platelet destruction by RES phagocytes
Pathophysiology
Pathogenesis
Acute ITP: Mainly affects children and usually follows a viral or bacterial infection
- Antigenic mimicry - Similar molecular structures on both host cells and infectious agents, inducing a self immune response which cross reacts with the host antigens.
- In acute ITP - anti-viral or anti-bacterial antibodies cross reacts against the patient's platelets.
- Mostly acute ITP is self resolving as infectious agents and antibodies are cleared from the body, causing the loss of anti-platelet reactivity.
- T cells are not involved in the parthenogenesis of acute ITP
Chronic AITP: (platelet counts < 150,000 x 109 per liter x 6 months) usually in adults
- Increased platelet destruction:
- Autoantibody‐induced platelet destruction
- Abnormal IgG auto-antibody recognizes glycoprotein IIb/IIIa, glycoprotein Ib/IX complex, GP Ia/IIa, and GP VI etc
- majority of these autoantibodies are IgG, but IgM and IgA can also be identified in some patients with AITP
- Predominantly IgG auto-antibodies constitute the majority of antibodies but IgM and IgA antibodies can also be found in some of ITP patients.
- Auto-antibodis binds to the circulating platelet membranes through glycoproteins
- Autoantibody-coated platelets induce Fcg receptors and bind to antigen-presenting cells (Splenic macrophages or dendritic cells) in the reticuloendothelial system
- The autoantibody-coated platelets undergo phagocytosis by splenic macrophages and peripheral blood neutrophils.
- Autoreactive T lymphocyte‐mediated platelet lysis
- Abnormal cytotoxic T cells defect leads to differentiation of direct autoreactive B cells further leading to secretion of IgG auto-antibodies.
- CD4-positive helper T cells react with platelet surface glycoproteins, through co-stimulation involving CD40:CD40L
- T cells act directly on the megakaryocytes in the bone marrow
- Autoantibody‐induced platelet destruction
- Autoantibody‐mediated suppression of platelet production:
- Decreased platelet turnover
- Abnormal thrombopoiesis
- Autoantibody‐induced suppression of megakaryocytopoiesis
- Megakaryocitic nuclei and cytoplasm shows degenrative changes
Genetics
Associated Conditions
Conditions associated with
Gross Pathology
On gross pathology, characteristic findings of itp include:
- Acute
- Chronic
Microscopic Pathology
On microscopic histopathological analysis, characteristic findings of itp include:
- Acute
- Chronic
References